High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial
高剂量口服和静脉注射利福平治疗以人类免疫缺陷病毒(HIV)阳性为主的乌干达成年人结核性脑膜炎:一项II期开放标签随机对照试验
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciab162
Cresswell, Fiona V; Meya, David B; Kagimu, Enock; Grint, Daniel; Te Brake, Lindsey; Kasibante, John; Martyn, Emily; Rutakingirwa, Morris; Quinn, Carson M; Okirwoth, Micheal; Tugume, Lillian; Ssembambulidde, Kenneth; Musubire, Abdu K; Bangdiwala, Ananta S; Buzibye, Allan; Muzoora, Conrad; Svensson, Elin M; Aarnoutse, Rob; Boulware, David R; Elliott, Alison M